Moleculin Biotech (MBRX) Reports FY22, Provides Pipeline Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. NVDA
2. HD
3. AMLX
4. METC
5. SPY
6. DOO
7. ARGX
8. KLAR
9. INFQ

Go back to Moleculin Biotech (MBRX) Reports FY22, Provides Pipeline Update
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.61 --0 (-0%)
Previous Close $0.61    52 Week High $9.58 
Open $0.60    52 Week Low $2.34 
Day High $0.66    P/E N/A 
Day Low $0.59    EPS $-0.34 
Volume 656,943